iiinova — where your digital self keeps evolving

iRadPulse @iradpulse.bsky.social · 25/03/2025

4/6 By 12 months: 📈 89.5% primary patency ✅ 68.2% improved Rutherford class 🦶 90% low/very low amputation risk (WIfI scores) ✨ No additional major amputations or target lesion revascularizations #VascularHealth #PatientOutcomes

100 0

iRadPulse @iradpulse.bsky.social · 25/03/2025

3/6 Results at 6 months: 🔹 11.5% primary safety events (1 mortality, 1 major amputation, 1 target lesion revascularization) 🔹 Late lumen loss: 0.7±0.7 mm 🔹 Negligible acute vessel recoil (2.4 mm to 2.3 mm)

100 0

iRadPulse @iradpulse.bsky.social · 25/03/2025

2/6 The DEEPER LIMUS study focused on patients with Rutherford class 3 to 5 infrapopliteal artery disease. Participants underwent vessel preparation with retrievable scaffold therapy followed by sirolimus-coated balloon angioplasty 💉 #InterventionalRadiology #VascularSurgery

100 0

iRadPulse @iradpulse.bsky.social · 25/03/2025

1/6 🚨 89.5% primary patency achieved in retrievable scaffold therapy with sirolimus-coated balloon angioplasty for infrapopliteal lesions! 🩺🌟 Check out the latest findings from CVIR in their DEEPER LIMUS study👇 #Infrapopliteal #Angioplasty #VascularHealth

110 0

iRadPulse @iradpulse.bsky.social · 21/03/2025

3/5 Key Findings: - Technical success: 100% - PTBDs removed median of 65 days post-procedure - Median follow-up: 2.8 years - Outcomes: No bile leakages or re-occlusions observed - Complications: None reported #PatientOutcomes #Safety

100 0

iRadPulse @iradpulse.bsky.social · 21/03/2025

2/5 Study Details: - Participants: 4 patients (mean age 56) - Background: Right posterior bile duct exclusion and bile leakage after liver/pancreatic surgery or liver transplant - Method: Fluoroscopy-guided PBNA followed by PTBD #Hepatology

100 0

iRadPulse @iradpulse.bsky.social · 21/03/2025

1/5 🚨 100% technical success in performing percutaneous biliary neo-anastomosis (PBNA) with fluoroscopy guidance!👇 Check out this recent study from CVIR exploring the safety and effectiveness of PBNA for challenging biliary conditions 🧵 #BiliaryIntervention #InterventionalRadiology

100 0

iRadPulse @iradpulse.bsky.social · 20/03/2025

3/6 Results: 📌 Post-transplant HCC recurrence: • Bridging: 1 patient (3%) • Downstaging: 4 patients (23.5%) 📌 Disease-free survival at 5 years: • Bridging: 86% • Downstaging: 65% (p < 0.05) #LiverDisease #Chemoembolization

100 0

iRadPulse @iradpulse.bsky.social · 20/03/2025

2/6 Study Focus: 🔍 286 patients undergoing liver transplantation for cirrhosis and early HCC (2006-2021) 🔍 53 received neoadjuvant TACE with doxorubicin-eluting microspheres 🔍 Two groups: Bridging (n=36) and downstaging (n=17) #TransplantSurgery #Oncology

100 0

iRadPulse @iradpulse.bsky.social · 20/03/2025

1/6 🚨 Only 3% post-transplant recurrence in liver transplants after bridging TACE with doxorubicin-eluting microspheres! Discover new insights from CVIR on transplant outcomes for HCC patients using this neoadjuvant technique 🧵 #LiverTransplant #HCC #TACE

120 0

iRadPulse @iradpulse.bsky.social · 18/03/2025

3/6 Challenges in the transition included: 🔹 Achieving financial independence from diagnostic radiology 🔹 Establishing a robust research program 🔹 Securing dedicated clinical facilities 🔹 Garnering strong institutional support #HealthcareLeadership #AcademicMedicine

100 0

iRadPulse @iradpulse.bsky.social · 18/03/2025

2/6 Background: The shift reflects IR's evolution from diagnostic radiology—a transition acknowledged by the 2012 Dual Primary Certificate in Interventional and Diagnostic Radiology by the American Board of Medical Specialties 📈 #MedicalEducation #Radiology

100 0

iRadPulse @iradpulse.bsky.social · 18/03/2025

1/6 🚨 Establishing independence: The University of Miami created its own Department of Interventional Radiology (IR) in 2016, a 3-year journey emphasizing IR's unique role in patient care. Let's dive into their key achievements and challenges! 👇 #InterventionalRadiology

100 0

iRadPulse @iradpulse.bsky.social · 18/03/2025

5/6 📝 Conclusion: CT-guided RFA shows promise as a safe and effective treatment for resectable pulmonary GGNs, especially when surgery is not an option. 🔗 Read the full study here: doi.org/doi:10.1007... #PatientCare #Radiology #MedTwitter #GGNs #InterventionalRadiology

100 0

iRadPulse @iradpulse.bsky.social · 18/03/2025

3/6 Key Results: ▪️ No local recurrence or distant metastasis in either group over ~2 years follow-up ▪️ RFA group had fewer postoperative complications (Clavien-Dindo classification) ▪️ Significantly lower pleural effusion rates in RFA group (P < 0.001) #Surgery

100 0

iRadPulse @iradpulse.bsky.social · 18/03/2025

2/6 Study Design: 🔹 Bi-center retrospective study 🔹 Patients with resectable pulmonary ground glass nodules (GGNs) 🔹 Compared CT-guided RFA (34 patients) vs. thoracoscopic sublobar resection (37 patients) 🔹 Focus on safety and efficacy outcomes #InterventionalRadiology

100 0

iRadPulse @iradpulse.bsky.social · 18/03/2025

1/6 🚨 CT-guided radiofrequency ablation (RFA) led to significantly fewer postoperative complications in pulmonary GGNs compared to thoracoscopic sublobar resection! Explore the latest study from CVIR comparing these interventions. 🩺✨ #PulmonaryNodules #RFA

110 0

iRadPulse @iradpulse.bsky.social · 13/03/2025

4/6 Results: 🔹 21 joints improved to VAS 0-3 🔹 7 joints remained at VAS 4-6 🔹 9 joints showed no improvement (VAS 7-10) 🔹 Minor complication: transient posterior thigh numbness in 2 patients, resolved within 30 days #VAS #PatientOutcomes

100 0

iRadPulse @iradpulse.bsky.social · 13/03/2025

1/6 🚨 64.5% of patients with great trochanteric pain syndrome (GTPS) showed improvement with LFCA embolization, as per the latest study results. Check out this new study from CVIR on managing hip pain when conservative treatments fail👇 #GTPS #Embolization

100 0

iRadPulse @iradpulse.bsky.social · 09/03/2025

5/6 📌 Conclusion: A tailored approach considering angiographic findings and clinical progression can be important when managing concurrent NCS and PCS. 🔗 Full study: doi.org/doi:10.1186... #VascularSurgery #PatientCare #ClinicalGuidelines #MedTwitter

100 0

iRadPulse @iradpulse.bsky.social · 09/03/2025

4/6 Results from four case scenarios demonstrate a nuanced decision-making process: ✅ Analyze angiographic findings. ✅ Tailor stenting based on the patient's vascular characteristics and symptoms. ✅ Different scenarios validate the personalized approach towards NCS & PCS.

100 0

iRadPulse @iradpulse.bsky.social · 09/03/2025

3/6 Key considerations: 🔹 NCS isn't a contraindication for ovarian vein embolization. 🔹 Decisions on simultaneous vs. sequential stenting rely on: - Detailed angiographic results - Patient's clinical progression #OvarianVeinEmbolization #InterventionalRadiology

100 0

iRadPulse @iradpulse.bsky.social · 09/03/2025

2/6 Management insights: 🔍 Analyses of renocaval pressure gradients often yield inconclusive results. 🔍 Evaluation of the left renal vein waveform can enhance diagnostic clarity. 🔍 "Test PTA" showing a balloon waist helps uncover significant stenosis. #VascularHealth #IR

100 0

iRadPulse @iradpulse.bsky.social · 09/03/2025

1/6 🚨 Discussing optimal strategies for managing nutcracker syndrome (NCS) and pelvic congestion syndrome (PCS)! Dive into the latest insights from CVIR Endovascular on treatment algorithms through four unique case studies 👇 #NutcrackerSyndrome #PelvicCongestionSyndrome

100 0

iRadPulse @iradpulse.bsky.social · 04/03/2025

1/6 🚨 Bypass surgery shows higher technical success (OR 8.50) but leads to more morbidity and mortality compared to endovascular interventions for PAD! Check out the latest study from JVIR that explores treatment approaches for Peripheral Artery Disease (PAD)👇 #PAD #IR

111 0

iRadPulse @iradpulse.bsky.social · 02/03/2025

1/6 🚨 Anesthesia protocols in interventional radiology (IR) are evolving rapidly to meet new clinical demands! Explore the latest insights from CVIR on optimizing anesthesia in IR procedures 🧵✨ #Anesthesia #InterventionalRadiology #PatientCare

100 0

iRadPulse @iradpulse.bsky.social · 28/02/2025

4/6 📊 Caution: The retrospective design and single-center setting suggest results should be interpreted carefully This study highlights potential benefits of combining PTAS with medical therapy for ICAS management #ClinicalResearch #PatientOutcomes

100 0

iRadPulse @iradpulse.bsky.social · 28/02/2025

3/6 Key Findings: ✅ Cumulative event rate significantly lower in PTAS group (11.6% vs. 34.9%, P=0.034) ✅ Median follow-up of 43 months ✅ No significant difference in ischemic strokes within 30 days or years 1-3, or secondary outcomes #VascularIntervention

100 0

iRadPulse @iradpulse.bsky.social · 28/02/2025

2/6 Study Design: 🔹 Retrospective review 🔹 Patients: Symptomatic severe ICAS with perfusion deficits 🔹 Interventions: PTAS group vs. MT alone 🔹 Analysis: Alberta Stroke Program Early CT score < 6 on mean transit time map #MedicalResearch #Cerebrovascular

100 0

iRadPulse @iradpulse.bsky.social · 28/02/2025

1/6 🚨 Percutaneous transluminal angioplasty & stenting (PTAS) + medical therapy (MT) dropped ischemic stroke risk to 11.6% vs. 34.9% with MT alone in severe ICAS patients! 📉 Explore new findings from CVIR on managing intracranial atherosclerotic stenosis (ICAS) 👇

100 0

iRadPulse @iradpulse.bsky.social · 26/02/2025

5/6 📌 Conclusion: In this study, Radiologic response criteria closely aligned with pathologic outcomes across various treatments without differences in efficacy. Full study: doi.org/doi:10.1016... #MedicalResearch #CancerTreatment

110 0

iRadPulse @iradpulse.bsky.social · 26/02/2025

1/6 🚨 68% of HCC tumors achieved a complete radiologic response after locoregional therapy (LRT) before liver transplantation! Explore the latest study from JVIR on radiologic-pathologic outcomes for various LRT modalities in HCC treatment 🧵👇 #HCC #Oncology #InterventionalRadiology

100 0

iRadPulse @iradpulse.bsky.social · 23/02/2025

4/6 Results: 🚀 Procedure success with minimal pain reported — only 1-2/10 intensity 🚀 No opioids or benzodiazepines required 🚀 Patient tolerated the procedure well and completed the embolization successfully #Safety #PainRelief

100 0

iRadPulse @iradpulse.bsky.social · 23/02/2025

3/6 Methodology: The pain management strategy included: 🛡️ Intraarterial ropivacaine in the uterine arteries 🛡️ Superior hypogastric nerve block with ropivacaine 🛡️ Intravenous acetaminophen for additional pain control #PainManagement #InnovativeCare

100 0

iRadPulse @iradpulse.bsky.social · 23/02/2025

2/6 Background: Standard sedation in uterine fibroid embolization involves fentanyl and midazolam, but not all patients tolerate these. This case focuses on a patient allergic to opioids and sensitive to midazolam, needing a unique pain relief approach during the procedure

100 0

iRadPulse @iradpulse.bsky.social · 23/02/2025

1/6 🚨 Successful uterine fibroid embolization with only 1-2/10 pain intensity using a novel non-opioid sedation method! Discover this case study from CVIR Endovascular for patients intolerant to traditional sedatives and analgesics🧵👇 #UterineHealth #Embolization

100 0

iRadPulse @iradpulse.bsky.social · 22/02/2025

1/6 🚨 Did you know that cancer pain is often the first symptom reported, significantly affecting quality of life? Discover insights on pain pathways and treatment options in the latest paper from CVIR, emphasizing multimodal analgesia💊 👇 #CancerPain #PainManagement

111 0

iRadPulse @iradpulse.bsky.social · 21/02/2025

1/6 🚨 Exploring interventional radiology's role in pediatric pain management! 🧒🔍 This newly published review from CVIR examines IR strategies like nerve blocks, ablation, and chemoembolization specifically for children's unique needs 👇 #PediatricPain

110 0

iRadPulse @iradpulse.bsky.social · 17/02/2025

3/5 Key Outcomes: - Median overall survival: HCC 19.0 months (95% CI, 16.1-22.4); CRLM 10.8 months (95% CI, 8.0-13.5) - No significant differences in effectiveness, safety, or HRQoL by reimbursement group - HRQoL stable with some functional and symptom fluctuations. #SurvivalRates #CancerResearch

100 0

iRadPulse @iradpulse.bsky.social · 17/02/2025

2/5 Study Design: A prospective, multicentre study involving 252 patients undergoing TARE with Y90 resin microspheres between August 2017 and July 2020 - 193 with HCC, 59 with CRLM - Data collected every 3 months for at least 24 months - Analyzed based on reimbursement criteria #Oncology

100 0

iRadPulse @iradpulse.bsky.social · 17/02/2025

1/5 🚨 The CIRSE CIRT-FR Registry reports a 13% serious adverse event rate in TARE Y90 therapy for liver cancers in France! 📊🔬 Explore the latest study from CVIR on outcomes of radioembolisation in HCC and colorectal liver metastases (CRLM) 🧵👇 #Y90

100 0

iRadPulse @iradpulse.bsky.social · 15/02/2025

4/6 Safety Profile: 🔴 1 pulmonary vascular injury and 1 hypotension case requiring vasopressors 🟢 No major bleeding or cardiac complications 🔵 7-day mortality: 2.1% (1 patient) 🟡 30-day mortality: 6.3% (3 patients) #InterventionalRadiology

100 0

iRadPulse @iradpulse.bsky.social · 15/02/2025

3/6 Results: 📊 95.8% technical success (46 out of 48 procedures) 📊 Mean PAP reduction of 3.6 mmHg 📊 RV to LV ratio decreased by -0.42 📊 Average post-procedure hospital stay of 5.7 days and ICU stay of 1.0 day 📉 Improved hemodynamics post-therapy! #Cardiology #Geriatrics

100 0

iRadPulse @iradpulse.bsky.social · 15/02/2025

1/6 🚨 Large-bore aspiration thrombectomy (LBAT) shows a 95.8% technical success rate for pulmonary embolism (PE) in patients aged ≥ 80 years! A new study from CVIRendo explores the safety & effectiveness of LBAT in octogenarians👇 #PulmonaryEmbolism

100 0

iRadPulse @iradpulse.bsky.social · 13/02/2025

4/6 Multivariate Findings: 🩺 Central renal vessel contact remains the most significant predictor of RUT 🩺 Tumors classified as T1b show increased risk compared to T1a These insights could refine risk assessments and procedure planning! 🤔🗺️ #KidneyCancer #OncologyStudies

100 0

iRadPulse @iradpulse.bsky.social · 13/02/2025

2/6 Study Scope: 🚑 EuRECA registry data (Dec 2014 - Nov 2020) 🚑 1,424 tumors from 11 centers 🚑 Focus on CT-guided techniques only 🚑 Primary outcome: Complete tumor ablation within 90 days #InterventionalRadiology #Oncology #RenalAblation

100 0

iRadPulse @iradpulse.bsky.social · 13/02/2025

1/6 🚨 97.3% Primary Technical Efficacy (PTE) achieved in CT-guided renal cryoablation for kidney tumors! Check out the latest study from CVIR on factors affecting efficacy and the role of tumor characteristics in Residual Unablated Tumor (RUT)👇 #RenalCryoablation

100 0

iRadPulse @iradpulse.bsky.social · 11/02/2025

4/6 Safety Profile: 🔍 Total adverse events (AEs): 408 🔍 Mild AEs: 78.4% 🔍 Moderate AEs: 3.9% 🔍 Severe AEs: 16.9% 🔍 Severe procedure-related AEs: 11.7% of patients #PatientSafety #LiverCancerTreatment #IR

100 0

iRadPulse @iradpulse.bsky.social · 11/02/2025

3/6 Key Results: ✅ Technical Success: 98.1% ✅ Technique Efficacy: 95.1% ✅ Local Tumor Progression: 11.9% at 12 months ✅ Overall Survival Rate: 95.5% at 12 months #Efficacy #CancerTreatment #SurvivalRate

100 0

iRadPulse @iradpulse.bsky.social · 11/02/2025

2/6 Study Overview: 🔍 NOLA registry data from 615 patients 🔍 MWA performed in 721 sessions for 760 liver tumors 🔍 Participants from healthcare centers in the US, Europe, and Asia #InterventionalRadiology #LiverTumors #GlobalHealthCare

100 0